From: Blood purification therapies in methotrexate-induced acute kidney injury: four case reports
 | Data before the start of blood purification | Blood purification method | Column used | Average reduction ratea | Days required for MTX to reach 0.1 μmol/L | Days required for serum Cre to decrease to its previous value | |
---|---|---|---|---|---|---|---|
MTX (μmol/L) | Serum Cre (mg/dL) | ||||||
Case 1 | 31.0 | 3.20 | HD → HDF | PES-15Sα® | HD 58.3 ± 6.17% HDF 40.0 ± 5.63% | 18 days | 40 days |
Case 2 | 23.0 | 1.80 | HP | CHS-350® | 55.3 ± 11.6% | 14 days | 18 days |
Case 3 | 62.4 | 3.75 | HD + HP | VPS-13HA®/PES-13Sα® (absorption column CHS-350®) | 56.1 ± 12.2% | 20 days | Approximately 50 days |
Case 4 | 183.6 | 4.23 | HD + HP | VPS-13HA® (absorption column CHS-350®) | 63.2% | ‑ | ‑ |